| Literature DB >> 27782861 |
Esmé G Trevelyan1, Warren A Turner2, Lynn Summerfield-Mann2, Nicola Robinson2.
Abstract
BACKGROUND: Post amputation, the complication of phantom limb pain (PLP) is prevalent and difficult to manage. This study aimed to determine whether it was feasible and acceptable to undertake a definitive multicentred randomised controlled trial assessing the effectiveness of acupuncture for treating lower limb amputees with PLP.Entities:
Keywords: Acupuncture; Amputation; Mixed-methods research; Phantom limb; Randomised controlled trial
Mesh:
Year: 2016 PMID: 27782861 PMCID: PMC5080724 DOI: 10.1186/s13063-016-1639-z
Source DB: PubMed Journal: Trials ISSN: 1745-6215 Impact factor: 2.279
Success of feasibility study
| A priori criteria | Findings | Objective met? (yes/no) |
|---|---|---|
| Recruitment rate was ≥2 participants per month fitting the eligibility criteria | Recruitment rate was 1.36 eligible participants per month | No |
| The study recruited ≥70 % of all eligible potential participants | 62.50 % of all eligible participants were recruited | No |
| Of the participants recruited to acupuncture group ≥90 % received their first acupuncture treatment within 1 week of recruitment | All participants received their first acupuncture treatment within 1 week of recruitment | Yes |
| After randomisation and allocation ≥90 % of participants received treatment as initially intended | All participants received treatment as intended and the study protocol was considered acceptable | Yes |
| Of the participants recruited to acupuncture group ≥80 % received all 8 acupuncture treatments | No participants received all 8 treatments (mean total number of treatments 5.14 (4.02–6.27)) | No |
| Of the participants recruited to usual care group ≤10 % dropped out of the study | One participant (14.29 %) of participants dropped out of the usual care group | No |
| At the primary endpoint of the study outcome measures were completed by ≥90 % of participants | 100 % of participants still enrolled on the study completed all outcome measures by the primary endpoint of the study | Yes |
| At 1 month after completion of the study, outcome measures were completed by ≥60 % of participants | Outcome measures were completed by 5 participants (33.33 %) | No |
| Qualitative data identified that outcome measures were acceptable and appropriate, that questionnaires and rating scales were easy to complete and that outcome measures could be identified for use in a definitive trial | Outcome measures were considered acceptable, appropriate and easy to complete. The HADS, PSS-10, EQ-5D-5 L, and ISI may not be appropriate for use in a definitive trial | Yes |
| Qualitative data implied that acupuncture was an acceptable and effective intervention for treating PLP with or without other secondary symptoms | Acupuncture/electroacupuncture was considered acceptable. Acupuncture was perceived to be effective at treating both PLP and other secondary complaints | Yes |
| Data were collected on the primary outcome measure (NRS) and effect size was calculated to inform a sample size calculation for a larger trial | Considering a 20 % dropout rate, 170 participants are recommended to be recruited to detect a significant change in a two-armed, parallel-group randomised controlled trial comparing usual care and acupuncture as measured using an 11-point NRS measuring average pain at 4 weeks | Yes |
| Qualitative and quantitative data implied that the acupuncture protocol used in the feasibility study was appropriate for use in a definitive multicentred randomised controlled trial | Participants did not drop out of the acupuncture group suggesting that it was acceptable. Participants’ symptoms generally improved over 6 treatments suggesting that 8 treatments was adequate. Acupuncture and electroacupuncture were considered acceptable, effective, and relaxing | Yes |
| The researcher was not aware which group participants had been enrolled to 100 % of the time | Blinding was not successful and the researcher knew through both participants and clinical staff at the amputee unit their group allocation | No |
EQ-5D-5 L EuroQol-5 dimensions, HADS Hospital Anxiety and Depression Scale, ISI Insomnia Severity Index, NRS numerical rating scale, PSS-10 Perceived Stress Scale 10-item, SF-MPQ-2 Short Form McGill Pain Questionnaire 2
Fig. 1Participant flow through the trial
Participant demographics
| Participant demographics | Acupuncture group ( | Control group ( |
|---|---|---|
| Age mean (±95 % CI) | 51.63 (40.38–62.87) | 55.71 (40.17–71.26) |
| Gender | ||
| Male | 6 (75.00) | 2 (28.57) |
| Female | 2 (25.00 ) | 5 (71.43) |
| Ethnicity | ||
| White British | 7 (87.50) | 4 (57.14) |
| Black Caribbean | 1 (12.50) | 1 (14.29) |
| Black African | 0 (0.00) | 1 (14.29) |
| White other | 0 (0.00 ) | 1 (14.29) |
| Employment status | ||
| Student | 0 (0.00) | 1 (14.29) |
| Unemployed | 1 (12.50) | 0 (0.00) |
| Sick leave | 5 (62.50) | 3 (42.86) |
| Retired | 2 (25.00) | 3 (42.86) |
| Time since amputation in days mean (±95 % CI) | 25.63 (18.43–32.85) | 29.43 (13.12–45.74) |
| Level of amputation | ||
| Above-knee | 2 (25.00 ) | 4 (57.14) |
| Below-knee | 6 (75.00) | 3 (42.86) |
| Reason for amputation | ||
| Vascular | 5 (62.50) | 3 (42.86) |
| Trauma | 2 (25.00) | 2 (28.57) |
| Infection | 0 (0.00) | 1 (14.29) |
| Other | 1 (12.50) | 1 (14.29) |
| History of past amputations? | ||
| Yes | 2 (25.00) | 1 (14.29) |
| No | 6 (75.00) | 6 (85.71) |
| General health | ||
| Diabetes I | 1 (12.50) | 0 (0.00) |
| Diabetes II | 3 (37.50) | 2 (28.57) |
| Cancer | 1 (12.50) | 0 (0.00) |
| Osteoarthritis | 1 (12.50) | 0 (0.00) |
| Epilepsy | 1 (12.50) | 0 (0.00) |
| Nil | 1 (12.50) | 5 (71.43) |
| Mobility level | ||
| Wheelchair user | 8 (100.00) | 7 (100.00) |
CI confidence interval
Fig. 2Box plot of ‘average pain’ intensity at baseline and day 28
Summary statistics at baseline and day 28 expressed as mean and between-group effect sizes
| Outcome measure | Group | Baseline mean (±95 % CI) | Between-group effect size (Cohen’s | Day 28 mean (±95 % CI) | Between-group effect size (Cohen’s |
|---|---|---|---|---|---|
| Number of participants who provided complete data | Acupuncture | 8 | 7 | ||
| Usual care | 7 | 5 | |||
| NRS average pain | Acupuncture | 5.44 (3.90–6.98) | 0.00 | 2.75 (0.31–5.19) | 0.64 |
| Usual care | 5.43 (3.75–7.11) | 4.43 (2.37–6.49) | |||
| NRS worst pain | Acupuncture | 8.00 (6.21–9.79) | 0.38 | 4.00 (0.40–7.60) | 0.69 |
| Usual care | 7.29 (5.80–8.77) | 6.29 (4.54–8.03) | |||
| SF-MPQ-2 | Acupuncture | 2.55 (1.70–3.40) | 0.21 | 1.06 (0.13–2.24) | 0.46 |
| Usual care | 2.85 (1.22–4.47) | 1.89 (0.07–3.85) | |||
| HADS anxiety | Acupuncture | 6.38 (2.75–10.00) | 0.29 | 5.25 (1.97–8.53) | 0.10 |
| Usual care | 5.29 (2.33–8.24) | 4.86 (1.38–8.34) | |||
| HADS depression | Acupuncture | 6.63 (3.34–9.91) | 0.35 | 0.35 5.75 (1.35–10.15) | 0.12 |
| Usual care | 5.14 (0.99–9.29 | 5.14 (0.99–9.29) | |||
| PSS-10 | Acupuncture | 15.25 (10.90–19.60) | 0.31 | 11.63 (5.43–17.82) | 0.48 |
| Usual care | 17.28 (10.11–24.46) | 15.57 (7.35–23.79) | |||
| ISI | Acupuncture | 13.50 (5.96–21.04) | 0.49 | 8.50 (1.65–15.35) | 0.14 |
| Usual care | 9.14 (0.93–17.35) | 7.42 (0.61–14.24) | |||
| EQ-5D-5 L mobility | Acupuncture | 4.88 (4.58–5.17) | 0.00 | 3.75 (2.88–4.62) | 0.47 |
| Usual care | 4.88 (4.58–5.17) | 4.29 (3.13–5.45) | |||
| EQ-5D-5 L self care | Acupuncture | 1.75 (1.16–2.34) | 0.24 | 1.63 (1.00–2.25) | 0.09 |
| Usual care | 1.57 (0.84–2.30) | 1.57 (1.08–2.07) | |||
| EQ-5D-5 L usual activities | Acupuncture | 3.75 (2.68–4.82) | 0.45 | 2.88 (2.18–3.57) | 0.84 |
| Usual care | 4.29 (3.26–5.31) | 3.71 (2.69–4.74) | |||
| EQ-5D-5 L pain-discomfort | Acupuncture | 3.50 (2.87–4.13) | 1.24 | 2.88 (2.18–3.57) | 0.44 |
| Usual care | 2.71 (2.26–3.17) | 2.57 (2.08–3.07) | |||
| EQ-5D-5 L anxiety/depression | Acupuncture | 2.00 (1.11–2.89) | 0.46 | 2.00 (1.23–2.77) | 0.50 |
| Usual care | 1.57 (0.84–2.30) | 1.57 (0.84–2.30) | |||
| EQ-5D-5 L health today | Acupuncture | 63.13 (46.41–79.84) | 0.21 | 74.63 (58.49–90.76) | 0.15 |
| Usual care | 67.14 (50.29–84.00) | 77.14 (63.05–91.23) | |||
| PGIC | Acupuncture | 5.71 (4.23–7.20) | 1.27 | ||
| Usual care | 3.20 (0.37–6.03) |
CI confidence interval, EQ-5D-5 L EuroQol-5 dimensions, HADS Hospital Anxiety and Depression Scale, ISI Insomnia Severity Index, NRS numerical rating scale, PGIC Patient Global Impression of Change, PSS-10 Perceived Stress Scale 10-item, SF-MPQ-2 Short Form McGill Pain Questionnaire 2
Acupuncture group participant quotes from semistructured interviews
| Theme | Quote |
|---|---|
| Scepticism and lack of expectations | ‘I was a bit worried about what it was all about. You said “acupuncture” and I said “I’m not keen on that”. And then I thought I’ll try it, I’ll try it out.’ (Interviewee 1) ‘Didn’t expect it to work. Very, very, very sceptical me, very. That’s how ignorant I was… I didn’t think it would work, I thought it was all nonsense.’ (Interviewee 4) |
| Being treated | ‘It was so relaxing… and, um, I was just lying there and I could have quite easily gone to sleep! It was so relaxing, so sort of peaceful.’ (Interviewee 2) |
| Changes in phantom limb pain | ‘I said “well, it’s good. It’s very good…” It works good and then last time she came she said “aren’t you going to have it?” I said “no, no, it’s got rid of that pain that was down there”.’ (Interviewee 1) |
| Factors affecting treatment | ‘She (the acupuncturist) looked after you well and I think that was a lot of it, her personality and the way she treated you and everything.’ (Interviewee 2) ‘I think because of the environment it was being done in and the timing more than anything, I think it wasn’t really a positive thing. It might have been a different story in another setting, if I had more time around my schedule.’ (Interviewee 3) |
| Completing the outcome measures | (Re the SF-MPQ-2) ‘ A couple of the wordings were a bit weird. I didn’t get some of the words on the describe the pain, gruelling and what was the other one? There were a couple of them I didn’t understand what these words meant.’ (Interviewee 4) |
| A good experience | ‘It’s been very positive… it’s been an extra benefit I would definitely say that… I couldn’t criticise anything to be perfectly honest.’ (Interviewee 5) |
SF-MPQ-2 Short Form McGill Pain Questionnaire 2